Britt van Erven
Papers
1
Total Citations
46
H-Index
1
About
Britt van Erven is a researcher whose work bridges the fields of metabolic disease and glycobiology, with a particular focus on classical galactosaemia. Her major contributions have centered on unraveling the molecular underpinnings of this rare genetic disorder, especially through the lens of immunoglobulin G (IgG) N-glycosylation. In her most-cited paper, "Classical galactosaemia: novel insights in IgG N-glycosylation and N-glycan biosynthesis" (2016, 46 citations), van Erven provided groundbreaking evidence that patients with classical galactosaemia exhibit distinct alterations in their IgG N-glycan profiles, shedding light on the disrupted N-glycan biosynthesis pathways that contribute to long-term complications. This work not only deepened the understanding of galactosaemia pathophysiology but also opened new avenues for potential biomarkers and therapeutic targets. By integrating clinical observations with advanced glycomic analyses, van Erven has positioned herself as a key figure in translating basic glycobiology into meaningful insights for rare disease management. Her research continues to inspire students and clinicians alike, demonstrating how meticulous investigation of a single metabolic pathway can yield profound implications for patient care.
Research Focus
Key Achievements
Top Papers
- 1